Azintuxizumab (Anti-SLAMF7 / CS1)
Azintuxizumab (Anti-SLAMF7 / CS1) is a monoclonal IgG4 bispecific antibody targeting B-cell maturation antigen (BCMA). It has the potential for the research of relapsed/refractory multiple myeloma (RRMM). MW :140.12 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3061 |
| Sku # | A3061-1mg*5 |
| Pricing | 1mg*5, $1690.00 |